Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
45
|
pubmed:dateCreated |
1997-12-12
|
pubmed:abstractText |
During experiments to identify putative hepatic receptors for thrombin-antithrombin (TAT) complexes, a 45-kDa protein was identified by ligand blotting. Following gel purification, amino acid sequencing revealed the 45-kDa TAT-binding polypeptide to be cytokeratin 18 (CK18). The presence of CK18 on the surface of intact rat hepatoma cells was demonstrated by binding of 125I-anti-CK18 antibodies. Anti-CK18 antibodies reduced the binding and internalization of 125I-TAT by rat hepatoma cells. Immunocytochemical analysis, to determine the location of CK18 in vivo, revealed a periportal gradient of CK18 staining; with hepatocytes around the portal triads demonstrating striking pericellular staining. In addition, anti-CK18 IgG associated with perfused livers to a significantly greater extent than preimmune IgG. Taken together, these data provide evidence that CK18 is found on the extracellular surface of hepatocytes and could play a role in TAT removal. Finally, these data, in conjunction with recent reports of CK8 (Hembrough, T. A., Li, L., and Gonias, S. L. (1996) J. Biol. Chem. 271, 25684-25691) and CK1 cell membrane surface expression (Schmaier, A. H. (1997) Thromb. Hemostasis 78, 101-107), indicate a novel role for these proteins as putative cellular receptors or cofactors to cellular receptors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antithrombin III,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, tat,
http://linkedlifedata.com/resource/pubmed/chemical/Keratins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/antithrombin III-protease complex
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
28574-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9353322-Animals,
pubmed-meshheading:9353322-Antibodies,
pubmed-meshheading:9353322-Antithrombin III,
pubmed-meshheading:9353322-Binding, Competitive,
pubmed-meshheading:9353322-Carcinoma, Hepatocellular,
pubmed-meshheading:9353322-Cattle,
pubmed-meshheading:9353322-Cell Membrane,
pubmed-meshheading:9353322-Gene Products, tat,
pubmed-meshheading:9353322-Humans,
pubmed-meshheading:9353322-Keratins,
pubmed-meshheading:9353322-Liver,
pubmed-meshheading:9353322-Liver Neoplasms,
pubmed-meshheading:9353322-Peptide Hydrolases,
pubmed-meshheading:9353322-Perfusion,
pubmed-meshheading:9353322-Rabbits,
pubmed-meshheading:9353322-Rats,
pubmed-meshheading:9353322-Surface Properties,
pubmed-meshheading:9353322-Tumor Cells, Cultured
|
pubmed:year |
1997
|
pubmed:articleTitle |
Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes.
|
pubmed:affiliation |
Department of Pathology, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|